18 February 2025 : Case report
Pulmonary Embolism Following Living Donor Hepatectomy: A Report of 4 Cases and Literature Review
Ling-Li Cui1ABCDEF, Xu-Ming Liu
1BCE, Liang Zhang 1BDF, Shen Liu1BF, Bo Wu2BF, Yun Wang1ADFG*, Zhi-Jun Zhu34ADF
DOI: 10.12659/AOT.946752
Ann Transplant 2025; 30:e946752
Table 1 Basic characteristic and treatment.
| Patient | Age (years) | Gender | BMI (kg/m2) | Surgery time (min) | Blood loss (mL) | Surgery type | Complications |
|---|---|---|---|---|---|---|---|
| 1 | 46 | Male | 27.3 | 260 | 100 | Right hepatectomy | None |
| 2 | 42 | Female | 26.3 | 240 | 200 | Left hepatectomy with MHV | None |
| 3 | 65 | Male | 23.5 | 280 | 800 | Right hepatectomy | Hypertension |
| 4 | 57 | Female | 23.2 | 223 | 200 | Left hepatectomy with MHV | None |
| 1 | Smoking | GCS (intraoperative and POD 1) | POD 2 | Dyspnea, chest tightness, fever, hypoxemia | Enhanced chest CT, venous ultrasound | Warfarin 4.5 mg/day orally Nadroparin calcium 0.4 mL/day subcutaneously | POD 15 |
| 2 | None | GCS (intraoperative and POD 1) | POD 8 | Dyspnea | Enhanced chest CT, venous ultrasound | Nadroparin calcium 0.4 mL/day subcutaneously, switched to rivaroxaban 10 mg/day orally after 5 days | POD 15 |
| 3 | Elderly | GCS (intraoperative and POD 1) | POD 4 | Nausea, dyspnea, hypoxemia | Enhanced chest CT, venous ultrasound | Nadroparin calcium 0.4 ml/day subcutaneously, switched to rivaroxaban 10 mg/day orally after 10 days | POD 19 |
| 4 | None | IPC (intraoperative) | POD 3 | Dyspnea | Enhanced chest CT, venous ultrasound | Heparin infusion pump, switched to low molecular weight heparin subcutaneous injection on the postoperative day 8, later switched to rivaroxaban 10 mg/day orally | POD 20 |
| GCS – graduated compression stockings; POD – postoperative day; MHV – middle hepatic vein; CT – computed tomography; IPC – intermittent pneumatic compression. | |||||||